LOC101929551: A Potential Drug Target for High-Temperature-Resistant Proteins
LOC101929551: A Potential Drug Target for High-Temperature-Resistant Proteins
LOC101929551 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of proteins known as the heat shock protein (HSP) family, which are known for their ability to withstand high levels of temperature and other stressors.
Recent studies have suggested that LOC101929551 may have interesting biological functions, including its potential as a drug target. One of the reasons for this is its known ability to interact with various signaling pathways, such as the signals pathway associated with cell proliferation and the angiogenesis pathway, which is responsible for the formation of new blood vessels.
Additionally, LOC101929551 has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration and invasion. These functions are important for the development and progression of many diseases, including cancer.
Furthermore, LOC101929551 has also been shown to be involved in the regulation of inflammation and immune response. This is important for diseases such as rheumatoid arthritis, where inflammation and an imbalance in the immune system can contribute to joint damage.
The search for potential drug targets and biomarkers is an ongoing process in the field of pharmacology, and LOC101929551 is an exciting example of a protein that may have potential as a drug target. Further research is needed to fully understand its functions and potential as a drug.
Protein Name: Uncharacterized LOC101929551
The "LOC101929551 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC101929551 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC101929555 | LOC101929563 | LOC101929578 | LOC101929615 | LOC101929622 | LOC101929633 | LOC101929698 | LOC101929707 | LOC101929710 | LOC101929713 | LOC101929718 | LOC101929727 | LOC101929755 | LOC101929761 | LOC101929762 | LOC101929772 | LOC101929788 | LOC101929996 | LOC101930053 | LOC101930071 | LOC101930098 | LOC101930112 | LOC101930129 | LOC101930496 | LOC102723311 | LOC102723313 | LOC102723321 | LOC102723323 | LOC102723340 | LOC102723341 | LOC102723342 | LOC102723345 | LOC102723364 | LOC102723370 | LOC102723376 | LOC102723403 | LOC102723409 | LOC102723439 | LOC102723446 | LOC102723475 | LOC102723490 | LOC102723493 | LOC102723517 | LOC102723536 | LOC102723553 | LOC102723560 | LOC102723564 | LOC102723566 | LOC102723568 | LOC102723576 | LOC102723596 | LOC102723639 | LOC102723686 | LOC102723692 | LOC102723724 | LOC102723739 | LOC102723750 | LOC102723769 | LOC102723834 | LOC102723838 | LOC102723850 | LOC102723878 | LOC102723890 | LOC102723906 | LOC102723911 | LOC102723914 | LOC102723944 | LOC102723961 | LOC102724001 | LOC102724012 | LOC102724019 | LOC102724023 | LOC102724034 | LOC102724036 | LOC102724058 | LOC102724080 | LOC102724081 | LOC102724087 | LOC102724104 | LOC102724122 | LOC102724137 | LOC102724142 | LOC102724145 | LOC102724192 | LOC102724229 | LOC102724288 | LOC102724322 | LOC102724355 | LOC102724428 | LOC102724429 | LOC102724434 | LOC102724438 | LOC102724467 | LOC102724497 | LOC102724511 | LOC102724520 | LOC102724527 | LOC102724528 | LOC102724542 | LOC102724551
